Voveran Ophtha Ophthalmic Solution
By Voveran Ophtha
5ml Ophthalmic Solution in a Packet

Composition
Diclofenac(0.1% w/v)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
October, 2025

liver
When it comes to the safety of Voveran Ophtha Ophthalmic Solution in relation to liver issues, it is important to note that no interactions have been found or established. This means that there is currently no specific caution or safety advice regarding the use of Voveran Ophtha Ophthalmic Solution for individuals with liver concerns. If you have any doubts or specific liver-related health conditions, it is always recommended to consult with your doctor for proper guidance before using Voveran Ophtha Ophthalmic Solution.

kidney
No interaction or effect on kidneys has been found with Voveran Ophtha Ophthalmic Solution.

alcohol
No interaction found between Alcohol and Voveran Ophtha Ophthalmic Solution. It is advisable to consult your doctor regarding the use of alcohol with this medication.

driving
Caution Avoid driving if vision is blurred after using Voveran Ophtha Ophthalmic Solution. Wait until vision clears to ensure safe driving.

pregnancy
During pregnancy, it is recommended to avoid using Voveran Ophtha Ophthalmic Solution as it may not be safe. Animal studies have indicated potential harm to the baby. Kindly discuss with your doctor for further guidance.

breastfeeding
Voveran Ophtha Ophthalmic Solution is considered safe while breastfeeding, based on limited data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | Phenylacetic acid Derivative |
Therapeutic Class | OPHTHAL |
Action Class | NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid) |
₹41.9
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025